ORPHA:761
Immunoglobulin A vasculitis
Also known as: Anaphylactoid purpura · Henoch-Schönlein purpura · IgA vasculitis · Purpura rheumatica · Rheumatoid purpura
Publications
13,210
Trials
16
Interventional, condition-specific
Researchers
1,057
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare, small-vessel vasculitis characterized by skin purpura, arthritis, abdominal and/or renal involvement, IgA tissue deposits (arterioles, capillaries, and venules) and circulating IgA immune complexes.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019167
- MeSH:D011695
- UMLS:C0034152
- NCIT:C34963
Additional Mondo synonyms (6)
HSP · Schoenlein-Henoch purpura · allergic purpura · anaphylactoid purpura · purpura rheumatica · rheumatoid purpura
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
13,210 matched papers (6,294 in last 10 years) Source
- Phenotype characterisedPresent
34 HPO annotations (e.g. Nausea and vomiting; Abdominal pain; Vasculitis) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
16 matched on ClinicalTrials.gov (9 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
34
Associated phenotypes · MONDO:0019167
- Nausea and vomiting
- Abdominal pain
- Vasculitis
- Arthritis
- Fever
Showing 5 of 34 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
20 associated chemicals · 34 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Hydroxychloroquine · therapeutic
- Methylprednisolone · therapeutic
- Acetaminophen · marker/mechanism
- Aspirin · marker/mechanism
- Benzoates · marker/mechanism
- Cefuroxime · marker/mechanism
- Ciprofloxacin · marker/mechanism
- Clarithromycin · marker/mechanism
- Cocaine · marker/mechanism
- Codeine · marker/mechanism
- Diclofenac · marker/mechanism
- Enalapril · marker/mechanism
Pathways: NF-kappa B signaling pathway; Phagosome; Complement and coagulation cascades; Pertussis; Legionellosis; Leishmaniasis; Chagas disease (American trypanosomiasis); Staphylococcus aureus infection
Literature
Is anyone studying this?
13,210
13,210 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
13,210 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
6,294 in the last 10 years · low confidence
Phrase hits: 13,210 · MeSH hits: 0
Who's working on it?
1,057
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Zhang X8 papers · 2026
Pediatric Hospital of the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Papers in Europe PMC - 02Wang Y7 papers · 2026
The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, 730000, Gansu, People's Republic of China.
Papers in Europe PMC - 03Xu Y7 papers · 2026
Pediatric Hospital of the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Papers in Europe PMC - 04Zhang L6 papers · 2026
Department of Pediatrics, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, China.
Papers in Europe PMC - 05Hu Y5 papers · 2026
Gastroenterology and Hepatology, , Affiliated Jinhua Hospital, Zhejiang University School of Medicine .
Papers in Europe PMC - 06Li L5 papers · 2026
The Second Department of Pediatric Internal Medicine, The First People's Hospital of Kashi, Kashi, Xinjiang, China.
Papers in Europe PMC - 07Ren X5 papers · 2026
Pediatric Hospital of the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Papers in Europe PMC - 08Zhang Y5 papers · 2026
Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Papers in Europe PMC - 09Boghițoiu D4 papers · 2025
Discipline of Pediatrics, Faculty of Dentistry, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Papers in Europe PMC - 10Chen J4 papers · 2026
Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan Province, People's Republic of China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
16
interventional trials for this specific condition
16 interventional trials matched this specific condition name; 9 currently recruiting in our sample. 186 trials are registered for vasculitis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
16 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 94.2th percentile).
low confidence · 94.2th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
16 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07595367·ENROLLING BY INVITATION·Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity Reaction (IgA) Vasculitis
Not reviewed·Conditions: Allergic Reaction (IgA) Vasculitis·Matched via name phrase
- NCT07315191·RECRUITING·Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Not reviewed·Conditions: Henoch Schönlein Purpura Nephritis·Matched via name phrase
- NCT05951517·RECRUITING·Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura
Not reviewed·Conditions: Henoch-Schönlein Purpura · Gastrointestinal Injury · Mycophenolate Mofetil·Matched via name phrase
- NCT05003986·RECRUITING·Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Not reviewed·Conditions: Focal Segmental Glomerulosclerosis · Minimal Change Disease · Immunoglobulin A Nephropathy · IgA Vasculitis·Matched via name phrase
- NCT07052981·NOT YET RECRUITING·Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis
Not reviewed·Conditions: IgA Nephropathy (IgAN) · IgAVN·Matched via name phrase
- NCT07024563·RECRUITING·Study of Ravulizumab in Pediatric Participants With Primary IgAN
Not reviewed·Conditions: IgAN · IgAVN · Immunoglobulin A Nephropathy · Immunoglobulin A Vasculitis Associated Nephritis·Matched via name phrase
- NCT06676384·RECRUITING·Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
Not reviewed·Conditions: IgA Nephropathy · Renal Insufficiency, Chronic · IgA Vasculitis · IGA Glomerulonephritis·Matched via name phrase
- NCT02939573·RECRUITING·A Randomized Multicenter Study for Isolated Skin Vasculitis
Not reviewed·Conditions: Primary Cutaneous Vasculitis · Cutaneous Polyarteritis Nodosa · IgA Vasculitis · Henoch-Schönlein Purpura·Matched via name phrase
- NCT03647852·RECRUITING·Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura
Not reviewed·Conditions: Henoch-Schönlein Purpura·Matched via name phrase
Broader category: vasculitis
186
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07388277·RECRUITING·CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Not reviewed·Conditions: Antineutrophil Cytoplasmic Antibody-associated Vasculitis·Matched via name phrase
- NCT06277427·RECRUITING·Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
Not reviewed·Conditions: Lupus Nephritis · ANCA Associated Vasculitis·Matched via name phrase
- NCT07448454·NOT YET RECRUITING·Role of Vessel Wall MRI in Differentiaition Between Intracranial Atherosclerotic Disease and Vasculitis as Causes of Ischemic Stroke
Not reviewed·Conditions: Intracranial Atherosclerotic Disease (ICAD) and Vasculitis·Matched via name phrase
- NCT07268521·NOT YET RECRUITING·A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab
Not reviewed·Conditions: Cryoglobulinemic Vasculitis (CV)·Matched via name phrase
- NCT07315087·RECRUITING·CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
Not reviewed·Conditions: SLE - Systemic Lupus Erythematosus · SSc-Systemic Sclerosis · IIM- Idiopathic Inflammatory Myopathies · ANCA Associated Vasculitis (AAV)·Matched via name phrase
- NCT06986018·NOT YET RECRUITING·Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV
Not reviewed·Conditions: Idiopathic Inflammatory Myopathies · ANCA-Associated Vasculitis·Matched via name phrase
- NCT06980597·RECRUITING·A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
Not reviewed·Conditions: Systemic Lupus Erythematosus (SLE) · Idiopathic Inflammatory Myopathy (IIM) · Systemic Sclerosis (SSc) · ANCA Associated Vasculitis (AAV)·Matched via name phrase
- NCT06821659·NOT YET RECRUITING·Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases
Not reviewed·Conditions: Systemic Lupus Erthematosus · Systemic Sclerosis (SSc) · Inflammatory Myopathies · ANCA Associated Vasculitis (AAV)·Matched via name phrase
- NCT06868290·RECRUITING·Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Not reviewed·Conditions: ANCA Associated Vasculitis (AAV)·Matched via name phrase
- NCT06335888·RECRUITING·A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
Not reviewed·Conditions: Giant Cell Arteritis·Matched via name phrase
- NCT07246096·RECRUITING·Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Not reviewed·Conditions: Autoimmune Diseases · Systemic Lupus Erythematosus · Systemic Sclerosis · Primary Sjögren Syndrome·Matched via name phrase
- NCT06611696·RECRUITING·Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
Not reviewed·Conditions: ANCA Associated Vasculitis (AAV)·Matched via name phrase
- NCT07339540·RECRUITING·the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
Not reviewed·Conditions: Recurrent or Refractory Systemic Lupus Erythematosus · Recurrent or Refractory IgG4 Related Diseases · Recurrent or Refractory Systemic Sclerosis · Recurrent or Refractory Idiopathic Inflammatory Myopathy·Matched via name phrase
- NCT03290456·RECRUITING·Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
Not reviewed·Conditions: Granulomatosis With Polyangitis·Matched via name phrase
- NCT07236801·RECRUITING·Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Not reviewed·Conditions: Systemic Lupus Erythematosus (SLE) · Systemic Sclerosis · Sjogren's Syndrome (SS) · Inflammatory Myopathy·Matched via name phrase
Observational and natural-history studies
9 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT03004326·RECRUITING·Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Not reviewed·Conditions: Cryoglobulinemic Vasculitis (CV) · Drug-induced Vasculitis · Eosinophilic Granulomatosis With Polyangiitis (EGPA) · IgA Vasculitis·Matched via name phrase
- NCT02593565·RECRUITING·Vasculitis Pregnancy Registry
Not reviewed·Conditions: Vasculitis · Behcet's Disease · CNS Vasculitis · Cryoglobulinemic Vasculitis·Matched via name phrase
- NCT07354503·NOT YET RECRUITING·Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis
Not reviewed·Conditions: IgAVN · IgA Vasculitis·Matched via name phrase
- NCT02967068·RECRUITING·VCRC Tissue Repository
Not reviewed·Conditions: Aortitis · Cutaneous Vasculitis · Eosinophilic Granulomatosis With Polyangiitis · Giant Cell Arteritis·Matched via name phrase
- NCT07664228·RECRUITING·I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis
Not reviewed·Conditions: IgA Vasculitis · Gastrointestinal Involvement·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 18 · after dedupe 18 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 18 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (18)
- ctis·2023-505497-14-00·Authorised, ongoing·A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15146958·Recruiting·A study of nipocalimab in adults with moderate to severe systemic lupus erythematosus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17045863·Not yet recruiting·The National Unified Renal Translational Research Enterprise for biosampling patients with rare kidney disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16128829·No longer recruiting·Understanding how treatments that reduce self-attacking immune proteins affect gene readouts in ANCA-associated vasculitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13069630·No longer recruiting·Obinutuzumab compared with rituximab for treating ANCA-associated vasculitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15354495·No longer recruiting·Randomised trial optimising COVID-19 vaccination in patients with chronic health conditions and a poor response to standard vaccination
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN19848432·No longer recruiting·Clinical trial to evaluate the safety and efficacy of CCX168 in ANCA-associated vasculitis (AAV)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN75434563·No longer recruiting·Mycophenolate mofetil versus cyclophosphamide for the induction of remission of childhood polyarteritis nodosa
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN55287110·No longer recruiting·Anti-CD20 monoclonal antibody therapy for type II mixed cryoglobulinemia syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN53663626·No longer recruiting·Study to evaluate the safety and efficacy of CCX168 in subjects with renal vasculitis on background cyclophosphamide treatment
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15366107·No longer recruiting·A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN07757494·No longer recruiting·Plasma exchange and glucocorticoid dosing in the treatment of antineutrophil cytoplasm antibody associated vasculitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN74038076·No longer recruiting·Sequential maintenance immunosuppression with mycophenolate and prednisolone: a randomised interventional trial in progressive immunoglobulin A nephritis (IgAN)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN97636235·No longer recruiting·Leflunomide treatment in progressive Immunoglobulin A Nephropathy (IgAN), a multi-centre, prospective, randomised controlled study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN03001669·No longer recruiting·European Community SYStemic VASculitis TRIALs group
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN73774524·No longer recruiting·A Pilot Randomised controlled trial of Methotrexate for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN68772788·No longer recruiting·Study to compare the treatment effects of Ginkgo biloba extract EGb 761® and Pentoxifylline in patients who suffer from tinnitus for more than three months and from psychological and social problems caused by the tinnitus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN71445600·No longer recruiting·Study to see if steroids reduce kidney problems in Henoch Schonlein purpura
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Immunoglobulin A vasculitis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Immunoglobulin A vasculitis" OR "Anaphylactoid purpura" OR "Henoch-Schönlein purpura" OR "IgA vasculitis" OR "Purpura rheumatica" OR "Rheumatoid purpura" OR "Schoenlein-Henoch purpura" OR "allergic purpura"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Immunoglobulin A vasculitis" OR "Anaphylactoid purpura" OR "Henoch-Schönlein purpura" OR "IgA vasculitis" OR "Purpura rheumatica" OR "Rheumatoid purpura" OR "Schoenlein-Henoch purpura" OR "allergic purpura"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 16 interventional · 9 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"vasculitis"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: HSP
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (13210) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T15:15:28.511Z
